Position in TTRX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$116,800
+$65,600 QoQ
Shares Held
16,000
0.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 29 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TTRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Composition Wealth, LLC holds $10,510,572 across 13 Biotechnology names. TTRX ranks #11 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,324 | $5,128,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,749 | $2,961,191 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
14,213 | $502,998 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
4,684 | $366,616 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
10,506 | $360,565 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,010 | $247,217 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
20,018 | $196,576 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
21,650 | $189,545 |
All Filings in TTRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,800 | 16,000 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $51,200 | 16,000 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $63,040 | 16,000 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||